Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek C Radisky

Showing results (131-140 of 173) with videos related to

Pageof 18
Sort By:
Breast Cancer Research and Treatment|November 15, 2022
Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriersJoshua Ogony, Tanya L Hoskin, Melody Stallings-Mann, et al.
Breast Cancer Research : BCR|December 21, 2017
Association between mammographic breast density and histologic features of benign breast diseaseKarthik Ghosh, Robert A Vierkant, Ryan D Frank, et al.
Cancer Research|February 12, 2009
Reactivation of suppressed RhoB is a critical step for the inhibition of anaplastic thyroid cancer growthLaura A Marlow, Lisa A Reynolds, Alan S Cleland, et al.
Oncotarget|February 9, 2018
Accelerated bottom-up drug design platform enables the discovery of novel stearoyl-CoA desaturase 1 inhibitors for cancer therapyChristina A von Roemeling, Thomas R Caulfield, Laura Marlow, et al.
Breast Cancer Research and Treatment|July 29, 2017
Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involutionMelody L Stallings-Mann, Ethan P Heinzen, Robert A Vierkant, et al.
Cancer Letters|March 8, 2021
MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescenceMarta Gabasa, Evette S Radisky, Rafael Ikemori, et al.
The American Journal of Pathology|August 30, 2011
Matrix metalloproteinase 3 is a mediator of pulmonary fibrosisCory M Yamashita, Lior Dolgonos, Rachel L Zemans, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|July 5, 2022
Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinomaPaula Duch, Natalia Díaz-Valdivia, Rafael Ikemori, et al.
Cell Death & Disease|March 30, 2026
Antagonistic SMAD2/3 control of TIMP-1, VEGF-A, and hypoxia signaling in myofibroblasts shapes histotype-specific angiogenesis in lung cancerNatalia Díaz-Valdivia, Paula Duch, Rafael Ikemori, et al.
Breast Cancer Research : BCR|May 2, 2026
Multi‑scale immune and spatial profiling of sclerosing adenosis and surrounding breast tissue identifies an immune‑cold field phenotype associated with breast cancer riskNicole Cruz-Reyes, Hongling Liang, Melody Stallings-Mann, et al.
Pageof 18

Showing results (131-140 of 173) with videos related to

Sort By:
Pageof 18
Breast Cancer Research and Treatment|November 15, 2022
Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriersJoshua Ogony, Tanya L Hoskin, Melody Stallings-Mann, et al.
Breast Cancer Research : BCR|December 21, 2017
Association between mammographic breast density and histologic features of benign breast diseaseKarthik Ghosh, Robert A Vierkant, Ryan D Frank, et al.
Cancer Research|February 12, 2009
Reactivation of suppressed RhoB is a critical step for the inhibition of anaplastic thyroid cancer growthLaura A Marlow, Lisa A Reynolds, Alan S Cleland, et al.
Oncotarget|February 9, 2018
Accelerated bottom-up drug design platform enables the discovery of novel stearoyl-CoA desaturase 1 inhibitors for cancer therapyChristina A von Roemeling, Thomas R Caulfield, Laura Marlow, et al.
Breast Cancer Research and Treatment|July 29, 2017
Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involutionMelody L Stallings-Mann, Ethan P Heinzen, Robert A Vierkant, et al.
Cancer Letters|March 8, 2021
MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescenceMarta Gabasa, Evette S Radisky, Rafael Ikemori, et al.
The American Journal of Pathology|August 30, 2011
Matrix metalloproteinase 3 is a mediator of pulmonary fibrosisCory M Yamashita, Lior Dolgonos, Rachel L Zemans, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|July 5, 2022
Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinomaPaula Duch, Natalia Díaz-Valdivia, Rafael Ikemori, et al.
Cell Death & Disease|March 30, 2026
Antagonistic SMAD2/3 control of TIMP-1, VEGF-A, and hypoxia signaling in myofibroblasts shapes histotype-specific angiogenesis in lung cancerNatalia Díaz-Valdivia, Paula Duch, Rafael Ikemori, et al.
Breast Cancer Research : BCR|May 2, 2026
Multi‑scale immune and spatial profiling of sclerosing adenosis and surrounding breast tissue identifies an immune‑cold field phenotype associated with breast cancer riskNicole Cruz-Reyes, Hongling Liang, Melody Stallings-Mann, et al.
Pageof 18